A Different Perspective on the Characterization of a New Degradation Product of Flibanserin With HPLC–DAD–ESI-IT-TOF-MS(n) and Its Pharmaceutical Formulation Analysis With Inter-Laboratory Comparison

BACKGROUND: Flibanserin (FLB) was first synthesized as an antidepressant drug; however, due to its enhancing effects on sexual activity, it was approved for treatment of hypoactive sexual desire disorder in women in 2015. OBJECTIVE: The aim of this study was to develop a new and fully validated HPLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Geven, Aysun, Özcan, Saniye, Levent, Serkan, Can, Nafiz Öncü
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560319/
https://www.ncbi.nlm.nih.gov/pubmed/37348556
http://dx.doi.org/10.1093/jaoacint/qsad074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560319/
https://www.ncbi.nlm.nih.gov/pubmed/37348556
http://dx.doi.org/10.1093/jaoacint/qsad074

Ejemplares similares